Biomea Fusion, Inc. NASDAQ:BMEA

Founder-led company

Biomea Fusion stock price today

$1.715
-2.28
-57.12%
Financial Health
0
1
2
3
4
5
6
7
8
9

Biomea Fusion stock price monthly change

-24.39%
month

Biomea Fusion stock price quarterly change

-24.39%
quarter

Biomea Fusion stock price yearly change

-72.56%
year

Biomea Fusion key metrics

Market Cap
147.15M
Enterprise value
692.43M
P/E
-10.54
EV/Sales
N/A
EV/EBITDA
-6.10
Price/Sales
N/A
Price/Book
7.38
PEG ratio
-0.37
EPS
-3.56
Revenue
N/A
EBITDA
-135.61M
Income
-127.26M
Revenue Q/Q
N/A
Revenue Y/Y
N/A
Profit margin
0%
Oper. margin
0%
Gross margin
0%
EBIT margin
0%
EBITDA margin
N/A
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

Biomea Fusion stock price history

Biomea Fusion stock forecast

Biomea Fusion financial statements

Average Price Target
Last Year

$20

Potential upside: 1066.18%

Based on estimate of 3 analysts
  • Analysts Price target

  • Financials & Ratios estimates

Biomea Fusion, Inc. (NASDAQ:BMEA): Profit margin
Jun 2023 0 -24.89M
Sep 2023 0 -28.42M
Dec 2023 6.14M -34.88M -567.96%
Mar 2024 0 -39.06M
Biomea Fusion, Inc. (NASDAQ:BMEA): Earnings per share (EPS)
2024-01-09 -0.85 -0.98
2024-04-01 -0.85 -0.98
2024-05-02 -1.02 -1.09
Biomea Fusion, Inc. (NASDAQ:BMEA): Debt to assets
Jun 2023 248674000 24.36M 9.8%
Sep 2023 225087000 25.47M 11.32%
Dec 2023 199927000 30.69M 15.35%
Mar 2024 168494000 33.18M 19.69%
Biomea Fusion, Inc. (NASDAQ:BMEA): Cash Flow
Jun 2023 -25.81M -417K 162.83M
Sep 2023 -23.89M -39K 138K
Dec 2023 -22.83M -8K 622K
Mar 2024 -32.03M -35K 116K

Biomea Fusion alternative data

Biomea Fusion, Inc. (NASDAQ:BMEA): Employee count
Aug 2023 86
Sep 2023 86
Oct 2023 86
Nov 2023 86
Dec 2023 86
Jan 2024 86
Feb 2024 86
Mar 2024 86
Apr 2024 86
May 2024 86
Jun 2024 110
Jul 2024 110

Biomea Fusion other data

19.46% -29.91%
of BMEA is owned by hedge funds
5.73M -8.74M
shares is hold by hedge funds

Biomea Fusion, Inc. (NASDAQ:BMEA): Insider trades (number of shares)
Period Buy Sel
Jun 2024 12509 0
Sep 2024 10000 0
Transaction Date Insider Security Shares Price per share Total value Source
Purchase
HITCHCOCK MICHAEL J.M. director
Common Stock 10,000 $10.06 $100,600
Purchase
VALLE FRANCO officer: Chief Financial Officer
Common Stock 12,509 $4.43 $55,365
Sale
A2A PHARMACEUTICALS, INC. 10 percent owner
Common Stock 50,000 $34.56 $1,728,150
Sale
A2A PHARMACEUTICALS, INC. 10 percent owner
Common Stock 75,000 $33.81 $2,535,750
Sale
A2A PHARMACEUTICALS, INC. 10 percent owner
Common Stock 25,000 $33.84 $846,000
Sale
A2A PHARMACEUTICALS, INC. 10 percent owner
Common Stock 150,000 $34.51 $5,175,750
Sale
A2A PHARMACEUTICALS, INC. 10 percent owner
Common Stock 100,000 $33.99 $3,399,300
Sale
A2A PHARMACEUTICALS, INC. 10 percent owner
Common Stock 200,000 $29.12 $5,823,800
Sale
A2A PHARMACEUTICALS, INC. 10 percent owner
Common Stock 200,000 $31.25 $6,250,000
Sale
A2A PHARMACEUTICALS, INC. 10 percent owner
Common Stock 200,000 $31.25 $6,250,000
Insider Compensation
Mr. Thomas Andrew Butler (1981) Co-Founder, Chairman & Chief Executive Officer $363,150
Mr. Ramses M. Erdtmann (1963) Co-Founder, Pres, Chief Operating Officer & Director
$36,190
Tuesday, 17 December 2024
https://thefly.com
benzinga.com
globenewswire.com
Monday, 16 December 2024
globenewswire.com
Thursday, 12 December 2024
globenewswire.com
Monday, 9 December 2024
globenewswire.com
Friday, 6 December 2024
globenewswire.com
Monday, 2 December 2024
globenewswire.com
Monday, 4 November 2024
accesswire.com
Sunday, 3 November 2024
accesswire.com
Saturday, 2 November 2024
accesswire.com
Friday, 1 November 2024
globenewswire.com
Wednesday, 30 October 2024
globenewswire.com
Tuesday, 29 October 2024
globenewswire.com
Sunday, 27 October 2024
accesswire.com
Saturday, 26 October 2024
accesswire.com
Monday, 21 October 2024
accesswire.com
globenewswire.com
Sunday, 20 October 2024
accesswire.com
Saturday, 19 October 2024
accesswire.com
Friday, 18 October 2024
accesswire.com
Thursday, 17 October 2024
accesswire.com
Wednesday, 16 October 2024
accesswire.com
Tuesday, 15 October 2024
globenewswire.com
accesswire.com
accesswire.com
Monday, 14 October 2024
accesswire.com
accesswire.com
Sunday, 13 October 2024
accesswire.com
Saturday, 12 October 2024
accesswire.com
  • What's the price of Biomea Fusion stock today?

    One share of Biomea Fusion stock can currently be purchased for approximately $1.72.

  • When is Biomea Fusion's next earnings date?

    Unfortunately, Biomea Fusion's (BMEA) next earnings date is currently unknown.

  • Does Biomea Fusion pay dividends?

    No, Biomea Fusion does not pay dividends.

  • How much money does Biomea Fusion make?

    Biomea Fusion has a market capitalization of 147.15M. Biomea Fusion made a loss 117.26M US dollars in net income (profit) last year or -$1.09 on an earnings per share basis.

  • What is Biomea Fusion's stock symbol?

    Biomea Fusion, Inc. is traded on the NASDAQ under the ticker symbol "BMEA".

  • What is Biomea Fusion's primary industry?

    Company operates in the Healthcare sector and Biotechnology industry.

  • How do i buy shares of Biomea Fusion?

    Shares of Biomea Fusion can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • Who are Biomea Fusion's key executives?

    Biomea Fusion's management team includes the following people:

    • Mr. Thomas Andrew Butler Co-Founder, Chairman & Chief Executive Officer(age: 44, pay: $363,150)
    • Mr. Ramses M. Erdtmann Co-Founder, Pres, Chief Operating Officer & Director(age: 62, pay: $36,190)
  • Is Biomea Fusion founder-led company?

    Yes, Biomea Fusion is a company led by its founders Mr. Thomas Andrew Butler and Mr. Ramses M. Erdtmann.

  • How many employees does Biomea Fusion have?

    As Jul 2024, Biomea Fusion employs 110 workers, which is 28% more then previous quarter.

  • When Biomea Fusion went public?

    Biomea Fusion, Inc. is publicly traded company for more then 4 years since IPO on 16 Apr 2021.

  • What is Biomea Fusion's official website?

    The official website for Biomea Fusion is biomeafusion.com.

  • Where are Biomea Fusion's headquarters?

    Biomea Fusion is headquartered at 900 Middlefield Road, Redwood City, CA.

  • How can i contact Biomea Fusion?

    Biomea Fusion's mailing address is 900 Middlefield Road, Redwood City, CA and company can be reached via phone at +65 09809099.

  • What is Biomea Fusion stock forecast & price target?

    Based on 3 Wall Street analysts` predicted price targets for Biomea Fusion in the last 12 months, the avarage price target is $20. The average price target represents a 1066.18% change from the last price of $1.72.

Biomea Fusion company profile:

Biomea Fusion, Inc.

biomeafusion.com
Exchange:

NASDAQ

Full time employees:

107

Industry:

Biotechnology

Sector:

Healthcare

Biomea Fusion, Inc., a biopharmaceutical company, focuses on the discovery and development of covalent small molecule drugs to treat patients with genetically defined cancers and metabolic diseases. Its lead product candidate is BMF-219, an orally bioavailable, potent, and selective covalent inhibitor of menin, a transcriptional regulator in oncogenic signaling in multiple cancers. The company was incorporated in 2017 and is headquartered in Redwood City, California.

900 Middlefield Road
Redwood City, CA 94063

CIK: 0001840439
ISIN: US09077A1060
CUSIP: 09077A106